Immune checkpoint inhibitors in advanced upper and lower tract urothelial carcinoma: a comparison of outcomes

SM Esagian, AR Khaki, LN Diamantopoulos… - BJU …, 2021 - Wiley Online Library
Objectives To compare clinical outcomes between patients with locally advanced
(unresectable) or metastatic urothelial carcinoma (aUC) in the upper and lower urinary tract …
被引用次数：23 相关文章

Immune checkpoint inhibitors in advanced upper and lower tract urothelial carcinoma: a comparison of outcomes

SM Esagian, AR Khaki, LN Diamantopoulos… - BJU …, 2021 - pure.johnshopkins.edu
Objectives: To compare clinical outcomes between patients with locally advanced
(unresectable) or metastatic urothelial carcinoma (aUC) in the upper and lower urinary tract …

Immune checkpoint inhibitors in advanced upper and lower tract urothelial carcinoma: a comparison of outcomes

SM Esagian, AR Khaki, LN Diamantopoulos… - 2021 - deepblue.lib.umich.edu
Immune checkpoint inhibitors in advanced upper and lower tract urothelial carcinoma: a
comparison of outcomes Page 1 Immune checkpoint inhibitors in advanced upper and lower …

Immune checkpoint inhibitors in advanced upper and lower tract urothelial carcinoma: a comparison of outcomes

SM Esagian, AR Khaki, LN Diamantopoulos… - BJU …, 2021 - iro.uiowa.edu
Objectives To compare clinical outcomes between patients with locally advanced
(unresectable) or metastatic urothelial carcinoma (aUC) in the upper and lower urinary tract …

[引用][C] Immune checkpoint inhibitors in advanced upper and lower tract urothelial carcinoma: a comparison of outcomes

SM Esagian, AR Khaki… - BJU …, 2021 - produccioncientifica.ucm.es

Immune checkpoint inhibitors in advanced upper and lower tract urothelial carcinoma: a comparison of outcomes

SM Esagian, AR Khaki, LN Diamantopoulos… - BJU …, 2021 - iris.uniupo.it
Objectives: To compare clinical outcomes between patients with locally advanced
(unresectable) or metastatic urothelial carcinoma (aUC) in the upper and lower urinary tract …

Immune checkpoint inhibitors in advanced upper and lower tract urothelial carcinoma: a comparison of outcomes

SM Esagian, AR Khaki, LN Diamantopoulos… - BJU …, 2021 - research.uniupo.it
Objectives: To compare clinical outcomes between patients with locally advanced
(unresectable) or metastatic urothelial carcinoma (aUC) in the upper and lower urinary tract …

Immune checkpoint inhibitors in advanced upper and lower tract urothelial carcinoma: a comparison of outcomes.

SM Esagian, AR Khaki, LN Diamantopoulos… - BJU …, 2021 - europepmc.org
Immune checkpoint inhibitors in advanced upper and lower tract urothelial carcinoma: a
comparison of outcomes. - Abstract - Europe PMC Sign in | Create an account https://orcid.org …

Immune checkpoint inhibitors in advanced upper and lower tract urothelial carcinoma: a comparison of outcomes

SM Esagian, AR Khaki, LN Diamantopoulos… - BJU …, 2021 - pure.psu.edu
Objectives: To compare clinical outcomes between patients with locally advanced
(unresectable) or metastatic urothelial carcinoma (aUC) in the upper and lower urinary tract …

Immune checkpoint inhibitors in advanced upper and lower tract urothelial carcinoma: a comparison of outcomes.

SM Esagian, AR Khaki, LN Diamantopoulos… - BJU …, 2021 - search.ebscohost.com
Objectives: To compare clinical outcomes between patients with locally advanced
(unresectable) or metastatic urothelial carcinoma (aUC) in the upper and lower urinary tract …